Cypress Capital LLC Increases Stock Holdings in Procter & Gamble Company (The) $PG

Cypress Capital LLC increased its stake in shares of Procter & Gamble Company (The) (NYSE:PG) by 2.3% during the 2nd quarter, according to its most recent filing with the SEC. The institutional investor owned 16,068 shares of the company’s stock after acquiring an additional 354 shares during the period. Procter & Gamble makes up approximately 0.7% of Cypress Capital LLC’s holdings, making the stock its 25th largest holding. Cypress Capital LLC’s holdings in Procter & Gamble were worth $2,560,000 at the end of the most recent reporting period.

Several other large investors also recently bought and sold shares of the company. Kingstone Capital Partners Texas LLC boosted its stake in shares of Procter & Gamble by 655,209.0% in the second quarter. Kingstone Capital Partners Texas LLC now owns 76,028,952 shares of the company’s stock valued at $11,832,680,000 after purchasing an additional 76,017,350 shares during the period. Northern Trust Corp increased its stake in Procter & Gamble by 0.8% during the 1st quarter. Northern Trust Corp now owns 29,644,000 shares of the company’s stock worth $5,051,930,000 after buying an additional 248,792 shares during the period. Price T Rowe Associates Inc. MD lifted its holdings in Procter & Gamble by 13.0% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 21,480,670 shares of the company’s stock worth $3,660,737,000 after buying an additional 2,466,308 shares in the last quarter. Goldman Sachs Group Inc. boosted its position in Procter & Gamble by 3.5% in the 1st quarter. Goldman Sachs Group Inc. now owns 17,405,539 shares of the company’s stock valued at $2,966,252,000 after buying an additional 583,629 shares during the last quarter. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its stake in shares of Procter & Gamble by 6.3% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 17,293,428 shares of the company’s stock valued at $2,947,146,000 after acquiring an additional 1,018,865 shares in the last quarter. Institutional investors and hedge funds own 65.77% of the company’s stock.

Insider Buying and Selling at Procter & Gamble

In other news, COO Shailesh Jejurikar sold 3,986 shares of the company’s stock in a transaction that occurred on Thursday, October 2nd. The stock was sold at an average price of $152.23, for a total transaction of $606,788.78. Following the completion of the transaction, the chief operating officer directly owned 46,899 shares of the company’s stock, valued at approximately $7,139,434.77. This represents a 7.83% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CFO Andre Schulten sold 4,252 shares of the stock in a transaction that occurred on Thursday, October 2nd. The stock was sold at an average price of $152.23, for a total value of $647,281.96. Following the sale, the chief financial officer owned 53,992 shares in the company, valued at $8,219,202.16. The trade was a 7.30% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last quarter, insiders have sold 150,488 shares of company stock worth $23,529,718. 0.20% of the stock is owned by company insiders.

Procter & Gamble Price Performance

Shares of PG opened at $146.90 on Monday. Procter & Gamble Company has a 52 week low of $144.46 and a 52 week high of $180.43. The company has a current ratio of 0.71, a quick ratio of 0.51 and a debt-to-equity ratio of 0.46. The firm has a market cap of $343.28 billion, a price-to-earnings ratio of 21.45, a PEG ratio of 3.87 and a beta of 0.36. The stock has a 50 day moving average of $152.93 and a 200-day moving average of $157.02.

Procter & Gamble (NYSE:PG) last announced its quarterly earnings data on Friday, October 24th. The company reported $1.99 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.90 by $0.09. The firm had revenue of $22.39 billion for the quarter, compared to analysts’ expectations of $22.23 billion. Procter & Gamble had a return on equity of 32.63% and a net margin of 19.74%.The firm’s revenue for the quarter was up 3.0% on a year-over-year basis. During the same period last year, the business posted $1.93 earnings per share. Procter & Gamble has set its FY 2026 guidance at 6.830-7.100 EPS. As a group, analysts forecast that Procter & Gamble Company will post 6.91 EPS for the current year.

Procter & Gamble Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Monday, November 17th. Stockholders of record on Friday, October 24th will be issued a $1.0568 dividend. The ex-dividend date of this dividend is Friday, October 24th. This represents a $4.23 annualized dividend and a dividend yield of 2.9%. Procter & Gamble’s payout ratio is 61.61%.

Analyst Ratings Changes

Several research analysts recently commented on the company. Bank of America cut their price target on Procter & Gamble from $180.00 to $174.00 and set a “buy” rating on the stock in a research note on Wednesday, October 8th. Morgan Stanley set a $175.00 price objective on Procter & Gamble in a report on Monday, October 27th. BNP Paribas Exane reduced their target price on Procter & Gamble from $177.00 to $172.00 and set an “outperform” rating for the company in a research note on Tuesday, September 23rd. BNP Paribas reissued an “outperform” rating and set a $177.00 price target on shares of Procter & Gamble in a research report on Friday, August 15th. Finally, Evercore ISI reaffirmed an “in-line” rating and issued a $170.00 price target (down from $190.00) on shares of Procter & Gamble in a report on Monday, July 14th. Twelve analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the stock. Based on data from MarketBeat.com, Procter & Gamble presently has an average rating of “Moderate Buy” and a consensus target price of $171.53.

Procter & Gamble Profile

Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.